Skip to content
Supreme Court Upends Purdue Pharma Opioid Settlement
Payback: Tracking Opioid Cash

Supreme Court Upends Purdue Pharma Opioid Settlement

In a 5-4 vote, the court ruled that the Sackler family cannot be shielded from future claims through Purdue’s bankruptcy.

Since the case was first heard, victims of the opioid crisis and recovery advocates have been split on the desired outcome. Some wanted the bankruptcy deal to go through so that settlement money could start flowing and fund urgently needed addiction services. Others said it would be unacceptable to allow the Sacklers to evade responsibility for their actions.

If you enjoyed this breakdown, follow the KFF Health News social team on Instagram @KFFHealthNews

✍️: Aneri Pattani/KFF Health News

More from This Investigation

Payback: Tracking the Opioid Settlement Cash

Opioid manufacturers and distributors are paying more than $54 billion in restitution to settle lawsuits about their role in the overdose epidemic, with little oversight on how the money is spent. We’re tracking how state and local governments use — or misuse — the cash.

Read More